EMA Speeds Up Review of Metastatic Pancreatic Cancer Drug
The European Medicines Agency’s (EMA) Committee for Medicinal Products for Human Use (CHMP) has initiated a phased review of data for daraxonrasib, a medicine...
Novartis to Acquire Myricx Bio to Expand Oncology Pipeline
Novartis has entered into a definitive agreement to purchase the United Kingdom-based biotechnology firm Myricx Bio. This acquisition is valued at a total of...
Generative AI Advancing Drug Research for Novel Therapeutics
The arduous journey of bringing a new drug from concept to patient has historically been fraught with staggering costs, extensive timelines, and a dishearteningly...
AI Solutions Cutting Drug Development Costs and Timelines
The pharmaceutical industry stands at a perennial crossroads, constantly balancing the imperative to innovate life-saving therapies with the daunting challenges of astronomical costs and...
AI Drug Target Discovery Unmasks Neurodegenerative Diseases
Neurodegenerative diseases represent one of the most formidable medical and societal challenges of our time. Conditions like Alzheimer's, Parkinson's, Amyotrophic Lateral Sclerosis (ALS), and...
AI Drug Discovery Fast-tracking Search for Cancer Treatment
The relentless pursuit of effective cancer treatments has long been a defining challenge in medical science. For decades, the arduous journey from a promising...
AI Drug Discovery Speeds Up Potential Cure for Rare Diseases
The landscape of medicine is constantly evolving, driven by an insatiable human desire to alleviate suffering and extend healthy lives. For too long, however,...
Subscribe Our Newsletter
White Papers
The Future of Digital Health
The pharmaceutical industry is acutely aware that the future of health and care, particularly in the United States, are trending toward a digital revolution....
Five Best Practices to Deliver Exceptional Multichannel Experiences
A one-size-fits-all customer journey no longer works. In the age of the consumer, the quality of the interaction is paramount. In this paper, we...
The Impact and Use of Social Media in Pharmacovigilance
Social media presents new channels and methods for biopharmaceutical companies to move away from traditional pharmacovigilance (PV) systems and safety reporting methods towards more...